SCHEMBL8800643

SCHEMBL8800643

CCOC(=O)C[n+]1c(C)csc1/N=C/N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 7/20 0.37
HTT P42858 3/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 6/20 0.36
GAA P10253 3/20 0.35
HSD17B10 Q99714 3/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8800647 1.00 MAPT (0.41) MAPTMAPK1ALDH1A1HTTTSHR
Bromide SCHEMBL1339378 0.99 MAPT (0.41) MAPTMAPK1ALDH1A1HTTTSHR
Bromide SCHEMBL1339379 0.99 MAPT (0.41) MAPTMAPK1ALDH1A1HTTTSHR
SCHEMBL4741560 0.80 MAPT (0.44) MAPTMAPK1ALDH1A1HTTTSHR
SCHEMBL4741561 0.80 MAPT (0.44) MAPTMAPK1ALDH1A1HTTTSHR
Bromide SCHEMBL1340344 0.79 MAPT (0.43) MAPTMAPK1ALDH1A1HTTTSHR
Bromide SCHEMBL4741193 0.79 MAPT (0.43) MAPTMAPK1ALDH1A1HTTTSHR
SCHEMBL12126784 0.78 ALDH1A1 (0.43) MAPTMAPK1ALDH1A1HTTTSHR
Bromide SCHEMBL2930327 0.77 ALDH1A1 (0.42) MAPTMAPK1ALDH1A1HTTTSHR
Bromide SCHEMBL2930328 0.77 ALDH1A1 (0.42) MAPTMAPK1ALDH1A1HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757692-A1 METHANOL DERIVATIVES FOR TREATMENT OF RETROVIRAL INFECTIONS ESPECIALLY HIV INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1997-02-12 EP disclosed